If the parent application published more than one year before the CIPs filing date, and if specific CIP claims rely on new matter (carrying only the CIPs later date), the published parent qualifies as 102(b) prior art against those claims
To this end, RGA developed a model to assess the potential impact of these drugs as treatments for weight loss in obese populations, and for diabetes on population mortality and morbidity, revealing significant potential reductions in cardiovascular incidence and mortality rates
Alternatives to GLP-1 Drugs GLP-1 agonists are not the only option for weight loss
Peptide therapy can be short- or long-term, depending on your needs and goals
Replinsh glycogen storage
For most women over 40, it's 1,6001,900